Sickle Cell Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

The global sickle cell disease treatment market size reached US$ 3.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2022-2028.

Sickle cell disease (SCD) is a genetic red blood cell (RBC) disorder that affects hemoglobin, a protein that carries oxygen throughout the body. It leads to many complications, such as acute chest syndrome, anemia, and vaso-occlusive crisis (VOC). At present, blood and bone marrow transplant is commonly suggested by doctors for treating SCD. It involves replacing affected bone marrow with a healthy substitute received from a donor. Other effective treatments, such as medications and blood transfusions, are also being utilized as they can reduce specific symptoms and prolong the life of patients.

A considerable increase in the number of individuals suffering from SCD represents one of the significant factors influencing the demand for new medications that can treat the condition effectively. As a result, the health regulatory authorities of numerous countries are focusing on fast-track approval of new treatment methods. For instance, the United States Food and Drug Administration (USFDA) approved a new medicine in 2019 to reduce the pain experienced by adults and children with SCD. Additionally, government authorities are supporting research and development (R&D) activities to encourage researchers and pharmaceutical companies to develop novel treatments. For instance, researchers at the National Heart, Lung, and Blood Institute (NHLBI) in the US are working on genetic therapies that can restore a missing gene or add a new DNA strain to improve the functioning of cells. These innovations, along with the rising disposable incomes and the growing awareness among individuals about the available healthcare services, are anticipated to contribute to market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global sickle cell disease treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on treatment type and end user.

Breakup by Treatment Type:

Blood Transfusion

Pharmacotherapy

Bone Marrow Transplant

Breakup by End User:

Hospitals

Diagnostic Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca Plc, Baxter International Inc., bluebird bio Inc., Bristol-Myers Squibb Company, CRISPR Therapeutics, Emmaus Medical Inc., Global Blood Therapeutics Inc., GlycoMimetics Inc., Novartis AG, Pfizer Inc. and Sangamo Therapeutics.

Key Questions Answered in This Report

1. What was the size of the global sickle cell disease treatment market in 2022?
2. What is the expected growth rate of the global sickle cell disease treatment market during 2023-2028?
3. What has been the impact of COVID-19 on the global sickle cell disease treatment market?
4. What are the key factors driving the global sickle cell disease treatment market?
5. What is the breakup of the global sickle cell disease treatment market based on the treatment type?
6. What is the breakup of the global sickle cell disease treatment market based on the end user?
7. What are the key regions in the global sickle cell disease treatment market?
8. Who are the key players/companies in the global sickle cell disease treatment market?

Product Code: SR112023A4076

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Sickle Cell Disease Treatment Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Treatment Type

6.1 Blood Transfusion
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Pharmacotherapy
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Bone Marrow Transplant
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by End User

7.1 Hospitals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Diagnostic Centers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 AstraZeneca Plc
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 Baxter International Inc.
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
  - 13.3.2.3 Financials
  - 13.3.2.4 SWOT Analysis
- 13.3.3 bluebird bio Inc.
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
  - 13.3.3.4 SWOT Analysis
- 13.3.4 Bristol-Myers Squibb Company
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 CRISPR Therapeutics
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 Financials
- 13.3.6 Emmaus Medical Inc.
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
  - 13.3.6.3 Financials
- 13.3.7 Global Blood Therapeutics Inc.
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
- 13.3.8 GlycoMimetics Inc.
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
  - 13.3.8.3 Financials
- 13.3.9 Novartis AG
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
  - 13.3.9.4 SWOT Analysis
- 13.3.10 Pfizer Inc.
  - 13.3.10.1 Company Overview
  - 13.3.10.2 Product Portfolio
  - 13.3.10.3 Financials
  - 13.3.10.4 SWOT Analysis
- 13.3.11 Sangamo Therapeutics
  - 13.3.11.1 Company Overview
  - 13.3.11.2 Product Portfolio
  - 13.3.11.3 Financials
  - 13.3.11.4 SWOT Analysis

Product Code: SR112023A4076

List of Figures

Figure 1: Global: Sickle Cell Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Sickle Cell Disease Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Sickle Cell Disease Treatment Market: Breakup by Treatment Type (in %), 2022
Figure 5: Global: Sickle Cell Disease Treatment Market: Breakup by End User (in %), 2022
Figure 6: Global: Sickle Cell Disease Treatment Market: Breakup by Region (in %), 2022
Figure 7: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Sickle Cell Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Sickle Cell Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Sickle Cell Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Sickle Cell Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: North America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: North America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: United States: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: United States: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Canada: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Canada: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Asia-Pacific: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Asia-Pacific: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: China: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: China: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Japan: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Japan: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: India: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: India: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: South Korea: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: South Korea: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Australia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Australia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Indonesia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Indonesia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Europe: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Europe: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Germany: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Germany: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: France: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: France: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: United Kingdom: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: United Kingdom: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Italy: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Italy: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Spain: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Spain: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Russia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Russia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Latin America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Latin America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Brazil: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Brazil: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Mexico: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Mexico: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Middle East and Africa: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Middle East and Africa: Sickle Cell Disease Treatment Market: Breakup by Country (in %), 2022
Figure 67: Middle East and Africa: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Global: Sickle Cell Disease Treatment Industry: SWOT Analysis
Figure 69: Global: Sickle Cell Disease Treatment Industry: Value Chain Analysis
Figure 70: Global: Sickle Cell Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Sickle Cell Disease Treatment Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 3: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 4: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Sickle Cell Disease Treatment Market: Competitive Structure
Table 6: Global: Sickle Cell Disease Treatment Market: Key Players

Sickle Cell Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Description

Table of Contents

List of Tables

Abstract

Key Market Segmentation:

Breakup by Treatment Type:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Sickle Cell Disease Treatment Market

6 Market Breakup by Treatment Type

7 Market Breakup by End User

8 Market Breakup by Region

9 SWOT Analysis

10 Value Chain Analysis

11 Porters Five Forces Analysis

12 Price Analysis

13 Competitive Landscape

List of Figures

List of Tables